Takehiro Fukami

532 total citations
14 papers, 230 citations indexed

About

Takehiro Fukami is a scholar working on Molecular Biology, Spectroscopy and Organic Chemistry. According to data from OpenAlex, Takehiro Fukami has authored 14 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Spectroscopy and 3 papers in Organic Chemistry. Recurrent topics in Takehiro Fukami's work include Analytical Chemistry and Chromatography (4 papers), Coenzyme Q10 studies and effects (2 papers) and Computational Drug Discovery Methods (2 papers). Takehiro Fukami is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Coenzyme Q10 studies and effects (2 papers) and Computational Drug Discovery Methods (2 papers). Takehiro Fukami collaborates with scholars based in Japan, Finland and United States. Takehiro Fukami's co-authors include Taro Yamashita, Tatsuji Nakamura, Hiroyuki Seimiya, Fumiyuki Shirai, Ikuko Nishimura, Haruka Yoshida, Yoko Yashiroda, Yukiko Muramatsu, Minoru Yoshida and Anna Mizutani and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Takehiro Fukami

14 papers receiving 224 citations

Peers

Takehiro Fukami
Duc T. Tran United States
Paul R. J. Davey United Kingdom
Zhihong O’Brien United States
Xianshu Yang United States
Duc T. Tran United States
Takehiro Fukami
Citations per year, relative to Takehiro Fukami Takehiro Fukami (= 1×) peers Duc T. Tran

Countries citing papers authored by Takehiro Fukami

Since Specialization
Citations

This map shows the geographic impact of Takehiro Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Fukami more than expected).

Fields of papers citing papers by Takehiro Fukami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Fukami. The network helps show where Takehiro Fukami may publish in the future.

Co-authorship network of co-authors of Takehiro Fukami

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Fukami. A scholar is included among the top collaborators of Takehiro Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Fukami. Takehiro Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Koda, Yasuko, Shin Sato, Hirofumi Yamamoto, et al.. (2022). Design and Synthesis of Tranylcypromine-Derived LSD1 Inhibitors with Improved hERG and Microsomal Stability Profiles. ACS Medicinal Chemistry Letters. 13(5). 848–854. 10 indexed citations
2.
Nara, Takeshi, Yukari Nakagawa, Keiko Tsuganezawa, et al.. (2021). The ubiquinone synthesis pathway is a promising drug target for Chagas disease. PLoS ONE. 16(2). e0243855–e0243855. 5 indexed citations
3.
Tanji, Kunikazu, Fumiaki Mori, Fumiyuki Shirai, et al.. (2020). Novel tankyrase inhibitors suppress TDP-43 aggregate formation. Biochemical and Biophysical Research Communications. 537. 85–92. 4 indexed citations
4.
Tsuganezawa, Keiko, Katsuhiko Sekimata, Yukari Nakagawa, et al.. (2019). Identification of small molecule inhibitors of human COQ7. Bioorganic & Medicinal Chemistry. 28(1). 115182–115182. 5 indexed citations
5.
Mizutani, Anna, Yoko Yashiroda, Yukiko Muramatsu, et al.. (2018). RK‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Cancer Science. 109(12). 4003–4014. 58 indexed citations
6.
Saito, Yoriko, Yoshiki Mochizuki, Ikuko Ogahara, et al.. (2017). Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways. Science Translational Medicine. 9(413). 12 indexed citations
7.
Nishimura, Ikuko, et al.. (2009). Improvement of the high-speed logD assay using an injection marker for the water plug aspiration/injection method. Journal of Chromatography A. 1216(15). 2984–2988. 12 indexed citations
8.
Ito, Masahiko, Junko Itô, Hidefumi Kitazawa, et al.. (2009). (−)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cells. Peptides. 30(6). 1074–1081. 20 indexed citations
9.
Yamashita, Taro, Ikuko Nishimura, Tatsuji Nakamura, & Takehiro Fukami. (2009). A System for LogD Screening of New Drug Candidates using a Water-Plug Injection Method and Automated Liquid Handler. JALA Journal of the Association for Laboratory Automation. 14(2). 76–81. 10 indexed citations
10.
Yamashita, Taro, et al.. (2008). High-speed solubility screening assay using ultra-performance liquid chromatography/mass spectrometry in drug discovery. Journal of Chromatography A. 1182(1). 72–76. 32 indexed citations
12.
Kawakami, Makoto, Shosuke Takemura, Tadao Kondo, Takehiro Fukami, & Toshio Goto. (1988). Chemical Structure of a New Modified Nucleoside Located in the Anticodon of Bombyx mori Glycine tRNA2. The Journal of Biochemistry. 104(1). 108–111. 10 indexed citations
13.
Yano, Mitsuo, et al.. (1984). Radioimmunoassay for clebopride, a new benzamide drug with antidopaminergic activity.. Chemical and Pharmaceutical Bulletin. 32(4). 1491–1497. 3 indexed citations
14.
Fukami, Takehiro, et al.. (1983). Determination of structure and absolute configuration of a new modified nucleoside isolated from tRNA-2Gly of Bombyx mori by a total synthesis to be 5-(S-carboxy(hydroxy)methyl) uridine.. PubMed. 127–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026